Bulletin
Investor Alert

Medtronic PLC

NYS: MDT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 7:51 p.m.

MDT
/zigman2/quotes/206816578/composite

$

103.16

Change

0.00 0.00%

Volume

Volume 147,002

Quotes are delayed by 20 min

/zigman2/quotes/206816578/composite

Previous close

$ 101.27

$ 103.16

Change

+1.89 +1.87%

Day low

Day high

$100.30

$103.65

Open

52 week low

52 week high

$72.13

$122.15

Open

Company Description

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Gr...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Valuation

P/E Current

29.10

P/E Ratio (with extraordinary items)

31.57

P/E Ratio (without extraordinary items)

28.02

Price to Sales Ratio

4.64

Price to Book Ratio

2.62

Price to Cash Flow Ratio

18.55

Enterprise Value to EBITDA

17.89

Enterprise Value to Sales

5.16

Total Debt to Enterprise Value

0.17

Efficiency

Revenue/Employee

321,256.00

Income Per Employee

53,211.00

Receivables Turnover

5.32

Total Asset Turnover

0.32

Liquidity

Current Ratio

2.13

Quick Ratio

1.72

Cash Ratio

1.06

Profitability

Gross Margin

61.87

Operating Margin

19.42

Pretax Margin

14.02

Net Margin

16.56

Return on Assets

5.31

Return on Equity

9.50

Return on Total Capital

7.38

Return on Invested Capital

6.47

Capital Structure

Total Debt to Total Equity

50.74

Total Debt to Total Capital

33.66

Total Debt to Total Assets

28.38

Long-Term Debt to Equity

44.93

Long-Term Debt to Total Capital

29.81

Officers and Executives

Name Age Officer Since Title
Dr. Omar S. Ishrak 63 2011 Executive Chairman
Mr. Geoffrey Straub Martha 49 2015 President & Director
Mr. Mark Ploof - 2016 Senior VP-Global Operations & Business Services
Ms. Karen L. Parkhill 54 2016 Chief Financial Officer & Executive Vice President
Dr. Richard E. Kuntz 63 2015 Senior VP, Chief Scientific & Clinical Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/23/2020 Robert J. W. ten Hoedt
EVP & President EMEA
9,584   Disposition at $104.34 per share. 999,994
09/15/2020 Karen L. Parkhill
EVP & Chief Financial Officer
702   Disposition at $107.78 per share. 75,661
09/09/2020 Robert J. W. ten Hoedt
EVP & President EMEA
9,563   Disposition at $105.05 per share. 1,004,593
08/03/2020 Michael J. Coyle
EVP & Group Pres, Cardiac&Vasc
9,453   Award at $0 per share. 0
08/03/2020 Karen L. Parkhill
EVP & Chief Financial Officer
9,042   Award at $0 per share. 0
08/03/2020 Geoffrey Straub Martha
CEO; Director
23,118   Award at $0 per share. 0
08/03/2020 Richard E. Kuntz
SVP & Chief Medical & Science
6,576   Award at $0 per share. 0
08/03/2020 Robert White
EVP & President MITG
7,398   Award at $0 per share. 0
08/03/2020 Bradley E. Lerman
SVP General Counsel & Corp Sec
8,117   Award at $0 per share. 0
08/03/2020 Carol A. Surface
SVP, Chief HR Officer
4,727   Award at $0 per share. 0
08/03/2020 Robert J. W. ten Hoedt
EVP & President EMEA
5,754   Award at $0 per share. 0
08/03/2020 John Randall Liddicoat
EVP & President of Americas
3,905   Award at $0 per share. 0
08/03/2020 Sean Salmon
EVP & Group President Diabetes
4,932   Award at $0 per share. 0
08/03/2020 Brett A. Wall
EVP & Group Pres Restora Thera
6,576   Award at $0 per share. 0
07/31/2020 Omar S. Ishrak
Executive Chairman; Director
26,082   Derivative/Non-derivative trans. at $96.48 per share. 2,516,391
07/31/2020 Michael J. Coyle
EVP & Group Pres, Cardiac&Vasc
7,922   Derivative/Non-derivative trans. at $96.48 per share. 764,314
07/31/2020 Karen L. Parkhill
EVP & Chief Financial Officer
6,339   Derivative/Non-derivative trans. at $96.48 per share. 611,586
07/31/2020 Geoffrey Straub Martha
CEO; Director
4,252   Derivative/Non-derivative trans. at $96.48 per share. 410,232
07/31/2020 Richard E. Kuntz
SVP & Chief Medical & Science
4,482   Derivative/Non-derivative trans. at $96.48 per share. 432,423
07/31/2020 Robert White
EVP & President MITG
2,727   Derivative/Non-derivative trans. at $96.48 per share. 263,100
07/31/2020 Bradley E. Lerman
SVP General Counsel & Corp Sec
5,411   Derivative/Non-derivative trans. at $96.48 per share. 522,053
07/31/2020 Carol A. Surface
SVP, Chief HR Officer
3,554   Derivative/Non-derivative trans. at $96.48 per share. 342,889
07/31/2020 Robert J. W. ten Hoedt
EVP & President EMEA
3,677   Derivative/Non-derivative trans. at $96.48 per share. 354,756
07/31/2020 John Randall Liddicoat
EVP & President of Americas
2,269   Derivative/Non-derivative trans. at $96.48 per share. 218,913
07/31/2020 Sean Salmon
EVP & Group President Diabetes
2,569   Derivative/Non-derivative trans. at $96.48 per share. 247,857
07/31/2020 Brett A. Wall
EVP & Group Pres Restora Thera
1,100   Derivative/Non-derivative trans. at $96.48 per share. 106,128
06/30/2020 Omar S. Ishrak
Executive Chairman; Director
22,508   Gift at $0 per share. 0
06/30/2020 Omar S. Ishrak
Executive Chairman; Director
22,508   Gift at $0 per share. 0
06/01/2020 Karen L. Parkhill
EVP & Chief Financial Officer
305   Gift at $0 per share. 0
06/01/2020 Karen L. Parkhill
EVP & Chief Financial Officer
305   Gift at $0 per share. 0
06/01/2020 Karen L. Parkhill
EVP & Chief Financial Officer
305   Gift at $0 per share. 0
06/01/2020 Karen L. Parkhill
EVP & Chief Financial Officer
305   Gift at $0 per share. 0
06/01/2020 Karen L. Parkhill
EVP & Chief Financial Officer
305   Gift at $0 per share. 0
06/01/2020 Karen L. Parkhill
EVP & Chief Financial Officer
305   Gift at $0 per share. 0
05/29/2020 Carol A. Surface
SVP, Chief HR Officer
2,000   Disposition at $97.72 per share. 195,440
04/29/2020 Richard H. Anderson
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 Denise M. O'Leary
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 James T. Lenehan
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 Randall J. Hogan
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 Kendall J. Powell
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 Craig Arnold
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 Scott C. Donnelly
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 Elizabeth G. Nabel
Director
393   Derivative/Non-derivative trans. at $99.14 per share. 38,962
04/29/2020 Andrea J. Goldsmith
Director
51   Derivative/Non-derivative trans. at $99.14 per share. 5,056
04/27/2020 Richard H. Anderson
Director
1,737   Award at $0 per share. 0
04/27/2020 Denise M. O'Leary
Director
1,737   Award at $0 per share. 0
04/27/2020 James T. Lenehan
Director
1,737   Award at $0 per share. 0
04/27/2020 Randall J. Hogan
Director
1,737   Award at $0 per share. 0
04/27/2020 Kendall J. Powell
Director
1,737   Award at $0 per share. 0
04/27/2020 Craig Arnold
Director
1,737   Award at $0 per share. 0
04/27/2020 Michael O. Leavitt
Director
1,737   Award at $0 per share. 0
04/27/2020 Scott C. Donnelly
Director
1,737   Award at $0 per share. 0
04/27/2020 Elizabeth G. Nabel
Director
1,737   Award at $0 per share. 0
04/27/2020 Andrea J. Goldsmith
Director
1,737   Award at $0 per share. 0
/news/latest/company/us/mdt

MarketWatch News on MDT

  1. The Pandemic Speeds Up the Health-Care Revolution

    8:37 p.m. Sept. 25, 2020

    - Lauren R. Rublin

  2. A Dozen Beaten-Up Stocks That Can Rocket Higher

    8:59 a.m. Sept. 16, 2020

    - Al Root

  3. Medtronic Says It Is Recovering From Covid Shock

    9:29 a.m. Aug. 25, 2020

    - Bill Alpert

  4. Medtronic shares up 5% premarket

    6:54 a.m. Aug. 25, 2020

    - Ciara Linnane

  5. Medtronic Q1 sales $6.507 bln vs. $7.493 bln; FactSet consensus $5.439 bln

    6:52 a.m. Aug. 25, 2020

    - Ciara Linnane

  6. Medtronic Q1 adj. EPS 62 cents; FactSet consensus 19 cents

    6:52 a.m. Aug. 25, 2020

    - Ciara Linnane

  7. Medtronic Q1 EPS 36 cents vs. 64 cents

    6:51 a.m. Aug. 25, 2020

    - Ciara Linnane

  8. Get Your Fixed-Income Fix in Dividend Stocks, Bernstein Analysts Say

    12:06 p.m. July 21, 2020

    - Lawrence C. Strauss

  9. Loading more headlines...
/news/nonmarketwatch/company/us/mdt

Other News on MDT

  1. Wall Street Breakfast: The Week Ahead

    12:06 p.m. Today

    - Seeking Alpha

  2. Medtronic scores win in patent dispute with Axonics

    2:32 p.m. Sept. 25, 2020

    - Seeking Alpha

  3. Medtronic prices €6.25B of senior notes

    4:33 p.m. Sept. 24, 2020

    - Seeking Alpha

  4. 9 Outbreak-Fueled Stocks to Buy This Week

    4:02 p.m. Sept. 23, 2020

    - InvestorPlace.com

  5. Medtronic TYRX Driveline Gets FDA's Breakthrough Designation

    11:22 a.m. Sept. 23, 2020

    - Zacks.com

  6. Medtronic driveline nabs accelerated review in U.S.

    9:14 a.m. Sept. 22, 2020

    - Seeking Alpha

  7. Medtronic (MDT) Gets a Buy Rating from Needham

    5:46 a.m. Sept. 22, 2020

    - SmarterAnalyst

  8. Medtronic's (MDT) TYRX Envelope Study Results Encouraging

    9:39 a.m. Sept. 21, 2020

    - Zacks.com

  9. 4 Stocks to Consider That Will Trade Ex-Dividend This Week

    9:28 a.m. Sept. 21, 2020

    - GuruFocus.com

  10. DexCom: A Superior Business Model But Watch Out For Debt Level

    11:22 a.m. Sept. 20, 2020

    - Seeking Alpha

  11. Dividend Champion And Contender Highlights: Week Of September 20

    11:34 a.m. Sept. 19, 2020

    - Seeking Alpha

  12. XLV: Healthcare Dashboard For September

    10:11 a.m. Sept. 16, 2020

    - Seeking Alpha

  13. Aziyo Biologics readies IPO

    6:41 a.m. Sept. 15, 2020

    - Seeking Alpha

  14. Medtronic Receives FDA's Go Ahead for EFS Study on TTVR

    9:29 a.m. Sept. 14, 2020

    - Zacks.com

  15. Loading more headlines...

At a Glance

Medtronic Plc

20 On Hatch

Lower Hatch Street

Dublin, Dublin 2

Phone

353 14381700

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

04/2021

Revenue

$28.91B

Net Income

$4.79B

Employees

90,000

/news/pressrelease/company/us/mdt

Press Releases on MDT

  1. Loading more headlines...
Link to MarketWatch's Slice.